MAP2K1 and breast carcinoma: A critical prosurvival role of MEK1 in breast cancer cells is supported by elegant studies from the Eastman laboratory, which demonstrated a more critical role of MEK1/MAPK signaling in breast cancer cell survival than that of Akt signaling [40].